长期酶替代疗法和Fabry病中的结局:系统性审查和元分析
Chih-Yang Chen1, Chun-Ting Li2, Cheng-Jui Lin1,3
1Division of Nephrology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei City 104217, Taiwan.
Biomedicines
|December 30, 2025
概括
随着时间的推移,法布里病患者的功能下降. 早期蛋白尿是加速衰退的关键指标,突出显示了迅速诊断和干预的必要性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 是一个遗传学.
- 罕见疾病 罕见疾病
背景情况:
- 费布里病是一种罕见的X链 lysosomal储存障碍.
- 它会导致逐渐的脏,心脏和神经系统并发症.
- 酶替代疗法 (ERT) 是标准的治疗方法,但其长期对的影响仍在争论中.
研究的目的:
- 系统地审查和分析法布里患者的结局.
- 评估ERT对功能的长期影响.
- 为了确定Fabry病衰退的预后因素.
主要方法:
- 16项研究 (2191名患者) 的系统综述和元分析.
- 数据提取估计的淋巴膜过率 (eGFR) 斜率,蛋白尿和临床事件.
- 随机效应模型和分组分析根据治疗状态和基线风险因素.
主要成果:
- 随着时间的推移,法布里患者的eGFR显著下降.
- 基线蛋白尿症 (UPCR > 0.5 g/g) 显著预测男性的EGFR下降速度更快.
- ERT显示下降速度较慢的趋势,特别是在功能维护和蛋白尿尿低的患者中.
结论:
- 尽管进行了治疗,但Fabry患者经历了渐进性的衰退.
- 基线蛋白尿是轨迹的主要决定因素.
- 早期诊断和干预至关重要,特别是在基线UPCR>0.5g/g的患者中.
关键词:
费布里病是什么意思 费布里病是什么意思临床事件 临床事件酶替代疗法 (ERT) 是一种酶替代疗法.球膜过率 (GFR) 是指球膜的过率.这是一个元分析.脏病是一种神经病.蛋白质尿症是一种蛋白质尿症.脏方面的结果.系统性审查 系统性审查更多相关视频
相关概念视频
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
162
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
162
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
197
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
197
Continuous Renal Replacement Therapy
722
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
722
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
165
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
165
Chronic Kidney Disease III: Interprofessional Care
319
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
319
Renal Failure: Dose Adjustments
401
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
401


